A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemia

被引：96

作者：

Estey, E

Kornblau, S

Pierce, S

Kantarjian, H

Beran, M

Keating, M

机构：

来源：

关键词：

D O I：

10.1182/blood.V88.2.756.bloodjournal882756

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：756 / 756

页数：1

共 8 条

[1] RESULTS OF THERAPY FOR ACUTE MYELOID-LEUKEMIA IN 1ST RELAPSE
ANGELOV, L
BRANDWEIN, JM
BAKER, MA
SCOTT, JG
SUTTON, DM
KEATING, A
[J]. LEUKEMIA & LYMPHOMA, 1991, 6 (01) : 15 - 24
[2] ESTEY E, IN PRESS LEUKEMIA
[3] HARRELL FE, 1985, CANCER TREAT REP, V69, P1071
[4] HIDDEMANN W, 1990, LEUKEMIA, V4, P184
[5] RESPONSE TO SALVAGE THERAPY AND SURVIVAL AFTER RELAPSE IN ACUTE MYELOGENOUS LEUKEMIA
KEATING, MJ
KANTARJIAN, H
SMITH, TL
ESTEY, E
WALTERS, R
ANDERSSON, B
BERAN, M
MCCREDIE, KB
FREIREICH, EJ
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (08) : 1071 - 1080
[6] SIMON R, 1984, CANCER TREAT REP, V68, P185
[7] SIMON R, 1985, CANCER TREAT REP, V69, P1375
[8] A BAYESIAN STRATEGY FOR SCREENING CANCER TREATMENTS PRIOR TO PHASE-II CLINICAL-EVALUATION
THALL, PF
ESTEY, EH
[J]. STATISTICS IN MEDICINE, 1993, 12 (13) : 1197 - 1211